Learning a novel technique to identify possible melanomas: are Australian general practitioners better than their U.K. colleagues? by Watson, Tony et al.
BioMed CentralAsia Pacific Family Medicine
ssOpen AcceResearch
Learning a novel technique to identify possible melanomas: are 
Australian general practitioners better than their U.K. colleagues?
Tony Watson1, Fiona M Walter1,2, Annabel Wood2, Helen Morris3, Per Hall3, 
Simone Karner1 and Jon Emery*1,2
Address: 1General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, WA, Australia, 2General Practice 
and Primary Care Research Unit, University of Cambridge, Cambridge, UK and 3Addenbrookes Hospital, NHS Foundation Trust, Cambridge, UK
Email: Tony Watson - Tony.Watson@uwa.edu.au; Fiona M Walter - fmw22@medschl.cam.ac.uk; Annabel Wood - areklaw@hotmail.com; 
Helen Morris - hcm29@medschl.cam.ac.uk; Per Hall - per.hall1@btinternet.com; Simone Karner - Simone.Karner@uwa.edu.au; 
Jon Emery* - Jon.Emery@uwa.edu.au
* Corresponding author    
Abstract
Background: Spectrophotometric intracutaneous analysis (SIAscopy™) is a multispectral imaging
technique that is used to identify 'suspicious' (i.e. potentially malignant) pigmented skin lesions for
further investigation. The MoleMate™ system is a hand-held scanner that captures SIAscopy™
images that are then classified by the clinician using a computerized diagnostic algorithm designed
for the primary health care setting. The objectives of this study were to test the effectiveness of a
computer program designed to train health care workers to identify the diagnostic features of
SIAscopy™ images and compare the results of a group of Australian and a group of English general
practitioners (GPs).
Methods: Thirty GPs recruited from the Perth (Western Australia) metropolitan area completed
the training program at a workshop held in March 2008. The accuracy and speed of their pre- and
post-test scores were then compared with those of a group of 18 GPs (including 10 GP registrars)
who completed a similar program at two workshops held in Cambridge (U.K.) in March and April,
2007.
Results: The median test score of the Australian GPs improved from 79.5% to 86.5% (median
increase 5.5%; p < 0.001) while the median test score of the English GPs improved from 74.5% to
86.5% (median increase 9.5%; p < 0.001). The Australian GPs had significantly higher pre-test scores
but there were no significant differences in post-test scores between the Australian and English GPs
or between the GPs and GP registrars. There was no significant difference in scores between GPs
with previous dermoscopy experience or dermatology training.
Conclusion: Most of the SIAscopy™ features can be learnt to a reasonable degree of accuracy
with this brief computer training program. Although the Australian GPs scored higher in the pre-
test, both groups had similar levels of accuracy and speed in interpreting the SIAscopy™ features
after completing the program. Scores were not affected by previous dermoscopy experience or
dermatology training, which suggests that the MoleMate™ system is relatively easy to learn.
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In Australia, skin cancer is the most common cancer, with
melanoma being the fourth most common registrable
cancer after prostate, colorectal, and breast cancer [1]. In
2003, there were 9,524 new cases of melanoma – a 14%
increase in incidence since 1993 – and 1,146 deaths (764
males and 382 females) [1]. The risk of developing
melanoma before the age of 75 is 1 in 24 for males and 1
in 34 for females [1]; melanoma is the most common can-
cer in the 20 to 39 year old age group [2].
Because the prognosis for melanoma is very good when
lesions are excised 'early' (97.9% 10-year survival ≤ 0.75
mm Breslow thickness) and poor when they are not (40%
10-year survival > 4 mm Breslow thickness), the National
Health and Medical Research Council has emphasized the
importance of the early diagnosis of melanoma [3]. When
compared with dermatologists, General Practitioners
(GPs) can be highly sensitive but less specific for the diag-
nosis of melanoma [4]; this results in a relatively high pro-
portion of excision biopsies [5] and secondary health care
referrals [6] of benign pigmented skin lesions (PSLs).
To improve the accuracy of melanoma diagnosis by GPs,
a variety of diagnostic algorithms and instruments have
been developed. The most widely-published, evaluated
and revised algorithms are the 'ABCD' [7] and 'Seven
Point' [8] checklists, each of which has a significant sensi-
tivity-specificity trade-off [9,10]. The most developed
diagnostic instruments utilize dermoscopy, multispectral
imaging, confocal laser microscopy, ultrasonography,
optical coherence tomography, or magnetic resonance
imaging [11]. Short training courses in dermoscopy, the
cheapest and most-evaluated method, have been shown
to increase the sensitivity of GPs for the diagnosis of
melanoma without increasing their specificity [12,13]. A
2002 systematic review of dermoscopy concluded that
"...dermoscopy improves the diagnostic accuracy for
melanoma in comparison with inspection by the unaided
eye, but only for experienced examiners" [14]. Clearly, to
reduce the number (and cost) of biopsies and referrals of
benign moles, GPs require more training and better tools
to improve the specificity of their diagnosis of melanoma.
The MoleMate™ system incorporates a hand-held scanner
that utilizes spectrophotometric intracutaneous analysis
(SIAscopy™) to produce images of the light-absorbing
chromophores haemoglobin, melanin and collagen in the
epidermis and papillary dermis. Certain features of these
images are combined with a customized diagnostic algo-
rithm to predict the 'suspiciousness', or 'potential malig-
nancy' of scanned lesions, indicating the need for biopsy
or referral. Using an algorithm derived from patients
referred to a hospital skin cancer clinic, SIAscopy™ has
been shown to have a sensitivity of 82.7% (95% confi-
dence interval [CI] 70.3% – 90.6%) and specificity of
80.1% (95% CI 75.1% – 84.2%) for the diagnosis of
melanoma [15]. Receiver-operator characteristic analysis
showed that the SIAscopy™ experts achieved a diagnostic
accuracy similar to that of 11 dermatologists with 9 hours
of dermoscopy training [16]. The MoleMate™ system,
which uses a diagnostic algorithm derived from patients
attending primary health care clinics, has been shown to
have a sensitivity of 100% (95% CI 44% – 100%) and spe-
cificity of 78% (95% CI 75% – 82%) for the diagnosis of
melanoma [17]. For comparison, a 2001 systematic
review of studies of unaided clinical diagnostic accuracy
for melanoma found that biopsy or referral sensitivity and
specificity were 82–100% and 70–89% for dermatologists
and 70–88% and 70–87% for Primary Care Physicians
(GPs) [18]. The MoleMate™ system is currently undergo-
ing a randomised controlled trial (RCT) in general prac-
tices in the east of England.
To facilitate the learning of the assessment of MoleMate™
scans by primary health care providers, a computer pro-
gram, the MoleMate™ training program, was developed by
the manufacturer, Astron Clinica™, and researchers from
Cambridge University. The self-administered program
takes approximately 90 minutes to complete and trains
users to identify the typical SIAscopic™ features of pig-
mented skin lesions including seborrhoeic keratoses, hae-
mangiomas, melanocytic naevi and melanomas.
In 2007, researchers from the University of Cambridge,
UK, tested the MoleMate™ training program on 18 GPs
[19]; the aim of this study was to test a similar group of
Australian GPs and compare the results.
Methods
MoleMate® images
The computer program produces a colour dermatoscopic
image and seven standard MoleMate™ images, or 'Views',
to assess each lesion (see Figure 1 for examples of 'Views').
MoleMate® training program
The computer-based training program consists of four,
self-administered sections:
1. Demonstration of the typical MoleMate™ features of 13
moles;
2. Pre-test of 30 MoleMate™ scans;
3. Tailored feedback of each pre-test answer for each scan
(see Figure 2 for a feedback example);
4. Post-test of 30 MoleMate™ scans.Page 2 of 5
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of correct answers and the time it takes for each lesion to
be assessed.
Workshops
In Cambridge, 18 GPs were recruited by flyer and email to
attend one of two evening workshops in Cambridge dur-
ing March and April 2007. In Perth, 31 GPs were recruited
by mail and email to attend an evening workshop in
March 2008. After a 10-minute demonstration of the
MoleMate™ system, the GPs were given 90 minutes,
including a refreshment break, to complete the training
program. One GP was unable to complete the program
due to a computer malfunction.
Analysis
Data were analysed using SPSS 15.0; pre- and post-test
scores were compared using the Wilcoxon Signed-Rank
Test for paired data and the Mann-Whitney U Test (using
the exact two-tailed probability test) for unpaired data; p
values less than 0.05 were regarded as statistically signifi-
cant.
Results
The personal data of the Australian and English GPs and
GP registrars are summarized in Table 1.
Effectiveness of the MoleMate® training program
Accuracy
The median pre- and post-test scores for the 30 Australian
GPs were 79.5% (inter-quartile range (IQR 73.8% –
85.0%) and 86.5% (IQR 81.0% – 90.0%): median
improvement 5.5% (IQR 1.0%–11.3%, p < 0.001).
The median pre- and post-test scores for the 18 English
GPs were 74.5% (IQR 70.8% – 79.0%) and 86.5% (IQR
82.5% – 89.0%): median improvement 9.5% (IQR 6.5%–
14.0%, p < 0.001).
The pre- and post-test scores for each MoleMate™ scan fea-
ture are shown in Figure 3. The Australian GPs signifi-
cantly improved their scores for all the features except for
the 'melanin brain' feature, while the English GPs signifi-
cantly improved their scores for all the features except for
the 'melanin brain' and 'dermal melanin' features.
The Australian GPs had higher pre-test scores than the
English GPs (p = 0.045) but, except for a lower score for
the 'dermal melanin' feature by the English GPs (p =
0.02), the post-test scores were not significantly different.
There were no significant differences between the total
pre- or post-test scores of the 8 English GPs and 10 English
GP registrars, but the registrars had significantly lower
scores for the 'dermal melanin' feature on the pre-test (p =
0.036) and for the 'melanin brain' feature on the post-test
(p = 0.016).
There were no significant differences in pre- or post-test
scores between Australian GPs who routinely used der-
moscopy and those who didn't and between English GPs
with post-graduate dermatology training and those with-
out.
Speed
The median average times taken by the Australian and
English GPs to assess each lesion decreased from 43 to 35
seconds (p < 0.001) and from 47 to 36 seconds (p <
0.001), respectively.
Overview of MoleMate™ training program showing 'Views'Figure 1
Overview of MoleMate™ training program showing 
'Views'.
Feedback section of MoleMate™ training programigure 2
Feedback section of MoleMate™ training program.Page 3 of 5
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test times between the 30 Australian and 18 English GPs
or between the 8 English GPs and 10 English GP registrars.
Discussion
The most remarkable finding of this study was the similar-
ity of the post-test scores of the Australian and English
GPs; although English GPs scored significantly lower on
the pre-test than the Australian GPs, their median post-
test score was identical, with only one feature (dermal
melanin) having a significantly lower score. Considering
that the pre- and post-test skin lesions were different for
both groups of GPs, and that the English GPs and GP reg-
istrars had similar post-test scores, the results suggest that
the MoleMate™ training program is effective, (i.e. it
improves the ability of individual GPs to assess SIAscopy™
features), and it is reliable (i.e. it is effective for different
groups of GPs).
Presumably, the Australian GPs scored higher than the
English GPs on the pre-test because they had more general
practice experience and more experience diagnosing PSLs.
Pre-test vs Post-test scores by MoleMate™ feature: Perth vs Cambridge GPsFigure 3
Pre-test vs Post-test scores by MoleMate™ feature: Perth vs Cambridge GPs.
Table 1: Summary of the personal data for GPs
Perth Cambridge
GPs GPs GP registrars
Average age (range) in years 51 (28–75) 48 (34–60) 31 (26–40)
Females 13 (43%) 4 (50%) 7 (70%)
Males 17 (57%) 4 (50%) 3 (30%)
Average years of general practice (range) 19 (2–45) 17 (9–25) 0.75 (0.5–1.0)
Routine use of dermoscopy 12 (40%) n/a n/a
Dermatology training n/a 5 (63%) 1 (10%)
n/a Not assessed.Page 4 of 5
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moscopy – some SIAscopy™ features are similar to those
seen with dermoscopy – there were no significant differ-
ences in pre- or post-test scores between those who did
and those who did not use dermoscopy. Similarly, there
were no significant differences in pre- or post-test scores
between the 33% of English GPs with postgraduate der-
matology training and those without. This suggests that
SIAscopy™ features are relatively easy to learn without pre-
vious dermatology experience.
Neither group improved their scores for the 'melanin
brain' feature, which, except for the uniqueness of the
image, is hard to explain; this feature is important for
identifying seborrhoeic keratoses, benign lesions that are
frequently referred to specialists.
GPs consistently scored greater than 90 percent for only
one feature: dermal melanin. Further research is required
to determine the amount of training GPs require to
achieve the accuracy of a MoleMate™ expert.
There are some significant limitations to this study: the
samples of GPs were small and not random, the English
GPs were less experienced, and diagnostic accuracy was
not evaluated. However, the training program was
designed as an introduction to the use of the MoleMate™
system in clinical practice and should not be considered a
stand-alone intervention. The training program and Mole-
Mate™ system are currently being evaluated in an RCT in
general practices in Cambridge, U.K.
Although the results of the SIAscopy™ feature testing can-
not be extrapolated to the clinical domain, the results of
the speed tests indicates that interpreting MoleMate™
scans would be relatively quick in clinical practice.
Conclusion
Most of the SIAscopy™ features can be learnt to a reasona-
ble degree of accuracy with this brief computer training
program. Although the Australian GPs scored higher in
the pre-test, both groups had similar levels of accuracy
and speed in interpreting the SIAscopy™ features after
completing the program. Scores were not affected by pre-
vious dermoscopy experience or dermatology training,
indicating that the MoleMate™ system is relatively easy to
learn without previous dermatology experience.
Competing interests
TW and the workshops were funded by Astron Clinica™.
Authors' contributions
JE, TW and SK conducted and analysed the Perth work-
shop. FW, PH, AW and HM conducted and analysed the
Cambridge workshops. JE and FW conceived the study
and helped draft the manuscript. TW performed the statis-
tical analysis and drafted the manuscript. All authors read
and approved the final manuscript.
References
1. AIHW (Australian Institute of Health and Welfare) & AACR (Austral-
asian Association of Cancer Registries) 2007: Cancer in Australia:
an overview, 2006.  In Cancer series no. 37. Cat. no. CAN 32 Can-
berra: AIHW. 
2. Australian Institute of Health and Welfare: Cancer incidence data
cubes:  [http://www.aihw.gov.au/cancer/data/datacubes/index.cfm].
accessed 4 April 2008.
3. National Health and Medical Research Council: Clinical practice
guidelines: the management of cutaneous melanoma.  Can-
berra: Australian Cancer Network; 1999. 
4. Burton RC, Howe C, Adamson L, Reid AL, Hersey P, Watson A,
Watt G, Relic J, Holt D, Thursfield V, Clarke P, Armstrong BK: Gen-
eral practitioner screening for melanoma: sensitivity, specif-
icity and effect of training.  J Med Screen 1998, 5:156-61.
5. English DR, Del Mar C, Burton RC: Factors influencing the
number needed to excise: excision rates of pigmented
lesions by general practitioners.  Med J Aust 2004, 180:16-19.
6. Morrison A, O'Loughlin SS, Powell FC: Suspected skin malig-
nancy: a comparison of family practitioners and dermatolo-
gists in 493 patients.  Int J Dermatol 2001, 40:104-7.
7. Friedman RJ, Rigel DS, Kopf AW: Early detection of malignant
melanoma: the role of physician examination and self-exam-
ination of the skin.  CA Cancer J Clin 1985, 35:130-51.
8. MacKie R: Clinical recognition of early invasive malignant
melanoma – looking for changes in size, shape, and colour is
successful.  Br Med J 1990, 301:1005-06.
9. Whited JD, Grichnik CM: Does this patient have a mole or
melanoma?  JAMA 1998, 279:696-701.
10. Liu W, Hill D, Gibbs AF, Tempany M, Howe C, Borland R, Morand M,
Kelly JW: What features do patients notice that help to distin-
guish between benign pigmented lesions and melanomas?:
the ABCD(E) rules versus the seven-point checklist.
Melanoma Res 2005, 15:549-54.
11. Marghoob AA, Swindle LD, Moricz CZ, Sanchez N, Slue S, Halpern A,
Kopf A: Instruments and new technologies for the in vivo
diagnosis of melanoma.  J Am Acad Dermatol 2003, 49:777-97.
12. Westerhoff K, McCarthy WH, Menzies SW: Increase in the sensi-
tivity for melanoma diagnosis by primary care physicians
using skin surface microscopy.  Br J Dermatol 2000, 143:1016-20.
13. Argenziano G, Puig S, Zalaudek I, Sera F, Corona R, Alsina M, Barbato
, Cristina Carrera F, Ferrara G, Guilabert A, Massi D, Moreno-
Romero J, Muñoz-Santos C, Petrillo G, Segura S, Soyer HP, Zanchini
R, Malvehy : Dermoscopy improves accuracy of primary care
physicians to triage lesions suggestive of skin cancer.  J Clin
Oncol 2006, 24:1877-82.
14. Kittler H, Pehamberger H, Wolff K, Binder M: Diagnostic accuracy
of dermoscopy.  Lancet Oncol 2002, 3:159-65.
15. Moncrieff M, Cotton S, Claridge E, Hall P: Spectrophotometric
intracutaneous analysis: a new technique for imaging pig-
mented skin lesions.  Br J Dermatol 2002, 146:448-57.
16. Binder M, Puespoeck-Schwarz M, Steiner A, Kittler H, Muellner M,
Wolff K, Pehamberger H: Epiluminescence microscopy of small
pigmented lesions: short-tem formal training improves the
diagnostic performance of dermatologists.  J Am Acad Dermatol
1997, 36:197-202.
17. Hunter J: Triaging suspicious pigmented skin lesions in pri-
mary care using the SIAscope.  In MD Thesis University of Cam-
bridge; 2007. 
18. Chen S, Bravata D, Weil E, Olkin I: A comparison of dermatolo-
gists' and primary car physicians' accuracy in diagnosing
melanoma: a systematic review.  Arch Dermatol 2001,
137:1627-34.
19. Wood A, Morris H, Emery J, Hall P, Cotton S, Prevost AT, Walter
FM: Evaluation of the MoleMate™ training programme for
assessment of suspicious pigmented lesions in primary care.
Inform Prim Care 2008, 16:41-50.Page 5 of 5
(page number not for citation purposes)
